| FacultyOctober 1, 2010
Hyatt Regency Washington on Capitol Hill
Washington, D.C.
Program Schedule
To view slides from a presenter click the icon next to the presentation title.
Friday, October 1, 2010 |
|
| 8:00 am - 8:15 am | Welcome & Overview: Monoclonal Antibodies in Cancer George J. Weiner, MD - University of Iowa |
| 8:15 am - 10:05 am | Session 1: Tumor-Targeted Antibodies Chair: Ira Mellman, PhD - Genentech, Inc. Targeting Activated HER2 in Solid Tumors Mark X. Sliwkowski, PhD - Genentech, Inc. Monoclonal Antibody ImmunotherapyLouis M. Weiner, MD - Georgetown University Medical Center Combining Tumor-Reactive mAbs with Cytokines to Induce ADCC in PatientsPaul M. Sondel, MD, PhD - University of Wisconsin, Madison |
| 10:30 am - 12:00 pm | Session 2: Immunomodulatory Antibodies Chair: Glenn Dranoff, MD - Dana-Farber Cancer Institute Immune Modulation by Antibody Lieping Chen, MD, PhD - Johns Hopkins University School of Medicine Immunomodulation with Antibodies Blocking the B7-H1/PD-1 Axis Suzanne L. Topalian, MD - Johns Hopkins University School of Medicine |
| 1:00 pm - 2:30 pm | Session 3: Investigating Antibodies as "Vaccines" Chair: Ira Mellman, PhD - Genentech, Inc. Antibody Therapeutics in Cancer: Converting Passive to Active Raphael Clynes, MD, PhD - Colubmia University Antibody-Targeted VaccinesTibor Keler, PhD - Celldex Therapeutics, Inc. |
| 3:00 pm - 5:00 pm | Session 4: Antibody Engineering Chair: George J. Weiner, MD - University of Iowa Two-in-One Antibody: From Proof-of-Concept to Therapeutic CandidateGermaine Fuh - Genentech, Inc. Engineered Anti-Cancer Antibodies with Enhanced Effector FunctionsPablo Umaña, PhD - Roche Glycart AG T Cell-Engaging Antibodies for Cancer TherapyPatrick A. Baeuerle, PhD - Micromet, Inc. |
Saturday, October 2 - Monday, October 4, 2010 |
|
| iSBTc 25th Annual Meeting For more information, please click here. |
|
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
